TruaceTracing the truth around AIThursday, August 27, 2026
The Index

What the evidence says.What the public feels.

Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.

1,169 results
Show filters and sorting

AI gains · 649

69
GainHealth· Newly added· Evidence: Moderate (1 source)

Machine learning analysis of breath volatiles identified candidate markers that discriminated culture-confirmed melioidosis from other febrile illnesses with perfect AUC in a small test set and tracked culture status and treatment time during antibiotics.

By the publication date of 2026-08-25, a pilot study had collected breath samples from 17 melioidosis patients and 8 febrile controls and used two-dimensional gas chromatography mass spectrometry combined with machine learning feature selection to identify volatile signatures of infection and treatment course.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%100

Updated Aug 26, 2026 · TRV-2026-0896

69
GainClimate· Newly added· Evidence: Moderate (1 source)

Domain-specific EfficientNet-B0 classifier and Claude Vision API with human-in-the-loop guidance automated morphological characterization of microplastics from optical microscope images, achieving high F1-scores for shape/type, color and texture.

Researchers compared a domain-specific EfficientNet-B0 multi-task deep learning classifier trained on about 700 annotated optical microscope images against a zero-shot Claude Vision API augmented with expert human-in-the-loop guidance. Both were tested on the same independent test set for predicting microplastic shape/type, color, and surface texture, with the DL model reaching F1-scores of 91.2%, 88.5% and 85.1% and the VLM improving from 72-81% to 84-89% after refinement.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%100

Updated Aug 26, 2026 · TRV-2026-0894

69
GainHealth· Newly added· Evidence: Moderate (1 source)

AI integration of chemical, biological and clinical data is supporting more informed rational drug design and has contributed to a small but growing number of AI-guided molecules entering clinical development.

This peer-reviewed review from August 2026 examines how machine learning, deep learning, NLP, and generative modeling are being used across medicinal chemistry, including target discovery, virtual screening, property prediction, de novo design, fragment optimization, ADMET assessment, and clinical trial design, with emphasis on multimodal data fusion and human-AI collaboration.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%100

Updated Aug 26, 2026 · TRV-2026-0893

69
GainHealth· Newly added· Evidence: Moderate (1 source)

When applied to reduce administrative burden, AI can optimize workflow and clinical precision and theoretically free nurses to deepen the therapeutic bond with patients.

This discursive paper from the Journal of Advanced Nursing analyzes AI integration in nursing through the Fundamentals of Care framework. It reports that AI offers benefits for workflow optimization and clinical precision via predictive analytics and automated documentation, and argues that reducing administrative burden could theoretically release time for relational care.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%100

Updated Aug 26, 2026 · TRV-2026-0892

AI problems · 520

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

AI applications in nutrition face persistent challenges with model transparency, ethical use of health data, and limited generalizability, particularly underrepresentation of low-resource settings.

A systematic review published October 14, 2025 synthesized peer-reviewed literature from January 2020 to July 2025 on AI in nutrition and dietetics, covering dietary assessment, personalized nutrition and chronic disease management, generative AI and conversational agents, public health nutrition, sensory science, and ethics.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 6, 2026 · TRV-2026-0669

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

Low-cost AI translations of oncology informed consent forms showed variable language equivalence and remain unsuitable for clinical use without human review.

On August 5, 2026, a peer-reviewed study in JCO Oncology Practice evaluated AI translation of three oncology clinical trial informed consent forms from English to Spanish, comparing DeepL Pro, ChatGPT-4o, and a medically trained model Med_English2Spanish against certified translations using five equivalence domains scored by two bilingual physicians.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 6, 2026 · TRV-2026-0663

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

AI chatbots used for intimate support regularly hallucinate clinical guidance, validate dysfunctional beliefs, handle crises without accountability, and may cultivate isolation.

On August 5, 2026, a viewpoint in the Journal of Participatory Medicine described how large language model chatbots and purpose-built companion agents are being used by millions for emotional support, distress processing, and relationship-like interaction, with 48.7% of people with self-reported mental health concerns reporting use for mental health support.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 6, 2026 · TRV-2026-0662

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

The same AI responses lacked guaranteed, verifiable sourcing and were not tested for actual patient comprehension, with authors noting need to adapt materials to meet health literacy standards before reliable use in safety-critical tracheostomy education.

On 2026-08-04, a peer-reviewed cross-sectional study reported testing ChatGPT4, Gemini 2.0, Copilot, DeepSeek V3, and Grok 3 on 12 tracheostomy care questions, with three blinded laryngologists rating responses for accuracy, completeness, clarity, and sourcing, and readability measured with nine metrics.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 5, 2026 · TRV-2026-0657

Recomputed live from the record · Aug 27, 2026, 7:45 PM